Product Code: ETC4470881 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The UAE Neurostimulation Market is witnessing significant growth as the demand for innovative healthcare solutions continues to rise. Neurostimulation involves the use of medical devices to modulate neural activity and manage various neurological conditions. Conditions such as chronic pain, Parkinson`s disease, and epilepsy are increasingly being treated with neurostimulation devices in the UAE. The market is driven by a growing aging population, increasing awareness about neurological disorders, and advancements in medical technology. Additionally, government initiatives and investments in healthcare infrastructure contribute to the market`s expansion.
Factors such as a rising number of patients with neurological disorders, increasing awareness about neurostimulation therapies, and technological innovations in neuromodulation devices drive the growth of the UAE neurostimulation market.
Challenges in the UAE Neurostimulation market include the limited awareness among both healthcare professionals and patients about the benefits and applications of neurostimulation therapies. Furthermore, high initial costs associated with these therapies might limit their accessibility to a broader patient base. Increasing awareness through educational programs and working towards reducing the financial barriers to access could enhance the acceptance and utilization of neurostimulation treatments.
The neurostimulation market in the UAE faced disruptions during the COVID-19 crisis as non-urgent medical services were limited. This led to a temporary decline in neurostimulation procedures for conditions such as chronic pain and neurological disorders. However, the market displayed adaptability by focusing on remote programming and patient management systems, contributing to the recovery as healthcare services gradually resumed.
In the UAE Neurostimulation market, key players such as Medtronic plc, Abbott Laboratories, and Boston Scientific Corporation are driving innovations in neuromodulation therapies. The market is characterized by the use of neurostimulation devices for the treatment of chronic pain, neurological disorders, and psychiatric conditions, providing patients with non-pharmacological and targeted therapeutic options.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Neurostimulation Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Neurostimulation Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Neurostimulation Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Arab Emirates (UAE) Neurostimulation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Neurostimulation Market Trends |
6 United Arab Emirates (UAE) Neurostimulation Market, By Types |
6.1 United Arab Emirates (UAE) Neurostimulation Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Spinal Cord Stimulator, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Deep Brain Stimulator, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Sacral Nerve Stimulator, 2021-2031F |
6.1.6 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Vagus Nerve Stimulator, 2021-2031F |
6.1.7 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Gastric Electric Stimulator, 2021-2031F |
6.2 United Arab Emirates (UAE) Neurostimulation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Pain Management, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Epilepsy, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Essential Tremor, 2021-2031F |
6.2.5 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Urinary and Fecal Incontinence, 2021-2031F |
6.2.6 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Depression, 2021-2031F |
6.2.7 United Arab Emirates (UAE) Neurostimulation Market Revenues & Volume, By Dystonia, 2021-2031F |
7 United Arab Emirates (UAE) Neurostimulation Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Neurostimulation Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Neurostimulation Market Imports from Major Countries |
8 United Arab Emirates (UAE) Neurostimulation Market Key Performance Indicators |
9 United Arab Emirates (UAE) Neurostimulation Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Neurostimulation Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Neurostimulation Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Arab Emirates (UAE) Neurostimulation Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Neurostimulation Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Neurostimulation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |